Pfizer Stories | Articles & Content Features

Go To Section

Articles
Announcements
Behind the Science Features
Podcasts
eBooks
Subscriptions

Articles

Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure

Roughly one in three Americans is at risk for heart failure1, a condition where the heart can no longer effectively pump blood. And one in four will develop heart failure at some point in their lives1. Behind these statistics is a complex issue: the causes of heart failure differ widely among affected individuals. And identifying the underlying cause – especially if it’s rare – can be tricky.Among the less recognized causes is transthyretin amyloid cardiomyopathy, or ATTR-CM, which can mimic....

You’ve Still Got It: Aging with Agency to Stay on Top of Your Health Year-Round

by Aamir Malik Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. and a member of Pfizer's Executive Leadership Team. Today, he writes about the importance of taking control of your health as you age, and shares advice from Leticia Acevedo, a North Carolina-based nursing professional and professor.Nowadays, people are striving to live their best lives — traveling, dancing, learning new skills, and embracing life with energy and purpose — all the while showing us....

Developing a Path Forward in Cancer Cachexia

Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions, such as cancer, and characterized by severe weight loss, decreased appetite, fatigue, and muscle wasting. Its symptoms can often be misattributed, and there are currently no FDA-approved treatments targeting its root cause.But, over the past decade, the....

How One Woman with Multiple Myeloma Found Strength—and Gratitude—in Adversity

September’s Blood Cancer Awareness Month is a time to raise awareness of hematologic cancers and share the stories of those living with the diseaseIn 2017, Lynce Lucas hadn’t been feeling well for several months and was dealing with some fractured ribs. But when she woke up one morning struggling with the ability to walk, she knew something more was wrong.Lynce was diagnosed with multiple myeloma, which at the time she didn’t know much about. “They told me that multiple myeloma was cancer, it....

Pfizer's Global Health Fellows Program: Leveraging Colleagues’ Expertise to Help Improve Healthcare Access Around the World

Global Health Fellows (GHF) is Pfizer’s signature skills-based volunteering program, empowering colleagues to lend their skills and expertise to global health partners in underserved communities around the world. For over 20 years, the program has helped to strengthen health systems and close the health equity gap in communities that need it most. Through the program, Pfizer colleagues have participated in pro bono consulting projects across Africa, Asia, Latin America, and the U.S., where they....

Not for Granted: Pediatric Immunization Through Experts’ Lens

New survey fielded by Excellence in Pediatrics Institute, with support from Pfizer, aims to uncover challenges and find solutions to gaps in pediatric vaccination rates in Europe

The Mindfulness of Medicine Development: How Scientists Are Driving the Next Wave of Medical Innovations

For millions of patients around the world, the development of a new treatment or vaccine can be life-changing. But the journey from promising drug candidate to approved product isn’t easy. It's a long and arduous process, with an average timeline lasting more than 10 years.Behind the scenes of these life-changing medical breakthroughs are the scientists whose dedication, expertise, and remarkable problem-solving skills are driving progress forward. Though their training could have prepared them....

Bridging Global Gaps in Hemophilia Care

Pfizer is proud of its commitment to advancing hemophilia care for more than 40 years, dating back to the introduction of recombinant therapies. But while there has been transformative progress as well as advances in the hemophilia treatment landscape during this time, there is still work to be done to ensure more patients receive the best care.Collaboration is an essential component of our efforts to increase access to treatment and bring breakthroughs to people with hemophilia and bleeding....

The Next Era of Decentralized Clinical Trials: The Clinical Trial Anywhere Model

During the early months of 2020, decentralized modalities to conduct clinical trials went mainstream as a solution to a short-term problem: how to continue clinical trials amid pandemic closures. At Pfizer, however, remote trials and the use of digital tools to conduct clinical trials were implemented long before the pandemic. Increased adoption of modalities like telehealth visits became catalysts for how — and where — clinical research could be done.What's more, surveys show that participants....

Behind the Science Features

What are ADCs? Targeting cancer with special drug delivery units

For centuries, humanity has hoped for a world where people with cancer live better, longer lives – and today that vision is closer than ever. Learn how antibody drug conjugates (ADCs) are emerging as one of the most powerful tools in cancer treatment.

Ever Wonder How Drugs Get Their Names?

Naming medications is not a simple process. It's a collaborative, conscientious effort, and one that is both an art and a science. Take a peek behind the curtain to see how drugs are named.

Understanding Obesity as a Complex Disease

Some people think obesity is simply caused by unhealthy eating habits and not exercising enough. But, in fact, the scientific and medical community defines obesity as a complex, multifactoral chronic disease.

See more Behind the Science Features